0 items USD 0.00Search
Your search for "globaldata hormone refractory castration resistant androgen independent prostate cancer global 0" gave back 137007 results.
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Castrate-resistant Prostate Cancer Report by...
Catalog:
9Dimen Research
November 2020
Price: USD 2,850.00
Summary HeyReport estimates that the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size will grow from xxx Million USD in...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Summary The Prostate Cancer market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Prostate Specific Antigen market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary The Prostate Specific Antigen market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Summary Publisher estimates that the Genitourinary Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Genitourinary Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Prostate cancer is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancerous death in men. In the...
Catalog:
9Dimen Research
July 2021
Price: USD 3,200.00
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer. Market Analysis and Insights: Global Androgen...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Summary The global Hormonal Contraception market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog:
HYR
January 2022
Price: USD 2,060.00
Summary Cancer Treatment Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
October 2020
Price: USD 2,960.00
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Benign Prostatic Hyperplasia Devices market size was valued at US$ 372.7 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
